Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review

Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review

Nadiya Nurul Afifah,1 Ajeng Diantini,1,2 Ruri Intania,3 Rizky Abdulah,1,2 Melisa I Barliana2,4 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia; 2Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universita...

Full description

Bibliographic Details
Main Authors:	Afifah NN, Diantini A, Intania R, Abdulah R, Barliana MI
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-10-01
Series:	Pharmacogenomics and Personalized Medicine
Subjects:	genetic polymorphism platinum-based chemotherapy dna repair drug accumulation drug detoxification.
Online Access:	https://www.dovepress.com/genetic-polymorphisms-and-the-efficacy-of-platinum-based-chemotherapy--peer-reviewed-article-PGPM

Similar Items

DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
by: Dimitra T. Stefanou, et al.
Published: (2021-12-01)

Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer
by: Jie Dong, et al.
Published: (2018-01-01)

Nanocarriers for platinum drug delivery
by: Qingfei Zhang, et al.
Published: (2023-06-01)

Systematic Investigation of DNA Methylation Associated With Platinum Chemotherapy Resistance Across 13 Cancer Types
by: Ruizheng Sun, et al.
Published: (2021-04-01)

Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
by: Paula Alfonso-Triguero, et al.
Published: (2023-05-01)

Platinum-based Cytotoxic Drugs in Hospital Effluent, Iasfahan, Iran
by: Samineh Dehghanpour, et al.
Published: (2020-02-01)

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
by: Jiabei Zhou, et al.
Published: (2020-03-01)

Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy
by: Yi-Xin Chen, et al.
Published: (2021-09-01)

Role of rs873601 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy
by: Ting Zou, et al.
Published: (2023-11-01)

The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
by: Ting Zou, et al.
Published: (2020-07-01)

Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
by: Ziwen Dai, et al.
Published: (2020-11-01)

The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients
by: He J, et al.
Published: (2022-09-01)

A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer
by: Miguel Cordova-Delgado, et al.
Published: (2021-09-01)

Evidence mapping of interactions on concomitant use of Chinese medicine and platinum-based chemotherapy: a scoping review protocol
by: Ai Ch’i Liew, et al.
Published: (2020-06-01)

DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
by: Nuno Tiago Tavares, et al.
Published: (2022-06-01)

Wireframe DNA Origami for the Cellular Delivery of Platinum(II)-Based Drugs
by: Erik De Luca, et al.
Published: (2023-11-01)

Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial
by: Sergei Krasny, et al.
Published: (2024-02-01)

Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition
by: Manman Xu, et al.
Published: (2022-12-01)

Using phosphine ligands with a biological role to modulate reactivity in novel platinum complexes
by: Marcelo Echeverri, et al.
Published: (2018-01-01)

Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer
by: Vanita Noronha, et al.
Published: (2012-01-01)

Platinum Complexes in Colorectal Cancer and Other Solid Tumors
by: Beate Köberle, et al.
Published: (2021-04-01)

Reductive prodrug and AIE copolymer nanoparticle for monitoring and chemotherapy
by: Zigui Wang, et al.
Published: (2024-03-01)

CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
by: Yonglin Yi, et al.
Published: (2022-01-01)

Nanocarriers containing platinum compounds for combination chemotherapy
by: Guihua Fang, et al.
Published: (2022-11-01)

Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion
by: Shiro Ueda, et al.
Published: (2010-09-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds
by: Sarah Schoch, et al.
Published: (2021-08-01)

Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells
by: Salma El-Shafie, et al.
Published: (2020-09-01)

Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer
by: Jiao Liu, et al.
Published: (2023-11-01)

Monofunctional Platinum(II) Anticancer Agents
by: Suxing Jin, et al.
Published: (2021-02-01)

Nanomaterial‐mediated platinum drug‐based combinatorial cancer therapy
by: Zhiqin Deng, et al.
Published: (2021-02-01)

Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis
by: Ning Tang, et al.
Published: (2017-06-01)

Efficacy of Bevacizumab Combined with Paclitaxel and Platinum-Based Chemotherapy in Advanced Metastatic Cervical Cancer and Its Effect on T Lymphocyte Subsets and Tumor Markers
by: WANG Lijun, et al.
Published: (2023-10-01)

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer
by: Linlin Zhang, et al.
Published: (2022-12-01)

Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma
by: Fubin Zhu, et al.
Published: (2023-09-01)

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
by: Roxan F.C.P.A. Helderman, et al.
Published: (2020-07-01)

Platinum Resistance in Ovarian Cancer: Role of DNA Repair
by: Giovanna Damia, et al.
Published: (2019-01-01)

Gemcitabine–oxaliplatin (GEMOX) for epithelial ovarian cancer patients resistant to platinum-based chemotherapy
by: Mohamed Elshebeiny, et al.
Published: (2016-09-01)

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents
by: Angelico D. Aputen, et al.
Published: (2023-04-01)

Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer — a pilot study
by: Janusz Milanowski, et al.
Published: (2012-04-01)